The verdictThe contracts are real and some are priced well: $4 per GPU-hour on the newest B300 deal against an implied ~$2.33 NVIDIA floor. Our re-test, though, found two new structural problems. Every phase of the $4.88B NVIDIA contract ends on the same date, so each month of build delay is revenue lost for good. And the ~$3.9B still to be funded must now be raised in a market where Firmus, its closest Australian peer, has…
Written by Claude (Anthropic’s AI) from public sources · Willem owns SHAZ · AI can make mistakes — numbers in brackets point to the sources · Not financial advice
Bull arguments show how well they survive the devil’s advocate (strong / medium / weak); bear arguments show the damage they could do after the counter-argument (high / medium / low).
Base for sizing: there is no reliable EPS. FY2026 consensus EPS is −$16.38 and FY2027 is −$7.94, both distorted by convertible fair-value losses, and FY2028 consensus was not found [29]. Impacts are therefore in EBITDA per share. Assumptions (estimates): 38.5M shares and a 60% incremental EBITDA margin. The margin is an estimate, not a company figure.
| # | Factor | Weight | Measured value | Score | Why |
|---|---|---|---|---|---|
| 1 | Liquidity & funding runway | 15% | Cash $1.86B (06-30) + $356M facility vs ~$6.1B commitments → ~$3.9B unfunded; Q2 underlying burn ~−$113M operating + −$268M advances | 72 | Operating cash lasts years, but the commitments due by mid-2027 don't fit. No going-concern language. |
| 2 | Leverage | 10% | Debt ~$1.41B ($1.05B converts + $356M facility) vs cash $1.86B; Q2 adj. EBITDA $0.6M; facility 9.95% with parent guarantee | 62 | Net cash on paper, but the cash is committed and EBITDA is ~zero, so the debt can't be serviced from operations yet. |
| 3 | Dilution | 10% | Class A 11.83M → 38.34M (+224%, Dec-25 → Sep-26); converts 14.3M (up to 24.1M max) + 1.1M options + plan evergreen | 95 | Far above the +25% anchor, with a large overhang. |
| 4 | Profitability | 10% | Q2 revenue $1.9M, loss from operations −$24.8M (−1,283% margin); H1 FCF ≈ −$430M excluding deposits | 85 | Pre-scale, deep losses. |
| 5 | Revenue quality & concentration | 10% | NVIDIA ~55% of TCV, ESDS ~14%; 2025 top 3 = 82% of revenue; no RPO disclosed | 78 | Above 35% with one counterparty, but multi-year take-or-pay. |
| 6 | Execution & track record | 10% | 1H-26 cluster slipped to Aug; $470M run-rate dropped; open material weakness; 10-Q/A; PR vs 10-Q EPS mismatch; three auditors | 82 | Material weakness plus restated comparisons and missed timing. |
| 7 | Competitive position | 10% | ~4 MW live; ClusterMAX lowest tier; no SOC 2/ISO; 212 MW secured; one of three Australian NVIDIA cloud partners | 65 | Contracted demand, but an easy-to-copy product with no proven operations. |
| 8 | Cyclicality & macro | 10% | Rental prices: H100 −57% in ~2.5 years; B200 forward −12%; stock −44% in 3 weeks on sector news | 68 | Take-or-pay softens it; resale, re-letting and funding are all cyclical. |
| 9 | Regulatory, legal & geopolitical | 5% | ESDS top client a sanctioned Russian bank (22%, FY25 H1); US export rules; AEMC large-load rule late Oct; Mawson litigation | 55 | Material but contained; no proceedings against SharonAI itself. |
| 10 | Valuation & expectations | 10% | Market cap $1.37B = 0.89× FY27 consensus; 6/6 Buy, targets $80–124; short ~12% of float | 58 | Cheap multiple, but consensus assumes perfect timing plus new sales. |
Overall: weighted average = 72.85 → 73. Change vs last: +2 against the old 6-area 71, and not a like-for-like comparison. The v3 method measures dilution (95) and profitability (85) directly, which lifts the score. Leverage (62) and valuation (58) pull it down because the June cash is still on the balance sheet.
Ranking check: SHAZ now ranks as the riskiest holding in the ledger, just above GRRR (72), because more of its value is still unbuilt and unfunded. GRRR's dilution is mechanically scheduled, while SHAZ must raise ~$3.9B. It sits clearly above IREN (69), which has live operations and a Microsoft contract already billing.